RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 144 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $200,794 | +12.0% | 26,880 | 0.0% | 0.03% | +17.4% |
Q1 2023 | $179,290 | -13.5% | 26,880 | 0.0% | 0.02% | -23.3% |
Q4 2022 | $207,245 | -27.5% | 26,880 | 0.0% | 0.03% | -40.0% |
Q3 2022 | $286,000 | +162.4% | 26,880 | +100.0% | 0.05% | +163.2% |
Q2 2022 | $109,000 | +13.5% | 13,440 | 0.0% | 0.02% | +35.7% |
Q1 2022 | $96,000 | – | 13,440 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |